Therapeutic effects of lenvatinib in combination with rAd-p53 for the treatment of non-small cell lung cancer

The aim of the present study was to analyze the effects of the combined treatment of lenvatinib and adenoviral delivered p53 gene (rAd-p53) on non-small cell lung cancer (NSCLC) cells and a total of 120 patients with NSCLC. The therapeutic effects of gene therapy of rAd-p53 and target therapy of Len...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Renzhi, Wang, Minghuan, Zhu, Xiuli, Sun, Zhe, Jiang, Aiying, Yao, Huixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202525/
https://www.ncbi.nlm.nih.gov/pubmed/30405797
http://dx.doi.org/10.3892/ol.2018.9428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202525/
https://www.ncbi.nlm.nih.gov/pubmed/30405797
http://dx.doi.org/10.3892/ol.2018.9428

Ejemplares similares